microtubule polymerization-inhibiting thienopyrimidine derivatives (Rigel Pharmaceuticals)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namemicrotubule polymerization-inhibiting thienopyrimidine derivatives (Rigel Pharmaceuticals)
Drug Alias NameN-cyclopropyl-2-(6-(3,5-dimethylphenyl)thieno[3,2-d]pyrimidin-4-yl)hydrazine (carbothioamide)R-253
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRigel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRigel Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A